|
1
|
Pan WL, Wong JH, Fang EF, Chan YS, Ng TB
and Cheung RC: Preferential cytotoxicity of the type I ribosome
inactivating protein alpha-momorcharin on human nasopharyngeal
carcinoma cells under normoxia and hypoxia. Biochem Pharmacol.
89:329–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tao Q and Chan AT: Nasopharyngeal
carcinoma: Molecular pathogenesis and therapeutic developments.
Expert Rev Mol Med. 9:1–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie SH, Yu IT, Tse LA, Mang OW and Yue L:
Sex difference in the incidence of nasopharyngeal carcinoma in Hong
Kong 1983–2008: Suggestion of a potential protective role of
oestrogen. Eur J Cancer. 49:150–155. 2013. View Article : Google Scholar
|
|
4
|
Zeng J, Dai P, Ren L, Song B, Chen X, Wang
X, Wang J, Zhang T and Zhu W: Apoptosis-induced anti-tumor effect
of Curcuma kwangsiensis polysaccharides against human
nasopharyngeal carcinoma cells. Carbohydr Polym. 89:1067–1072.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hildesheim A and Levine PH: Etiology of
nasopharyngeal carcinoma: A review. Epidemiol Rev. 15:466–485.
1993.PubMed/NCBI
|
|
6
|
Jia WH and Qin HD: Non-viral environmental
risk factors for nasopharyngeal carcinoma: A systematic review.
Semin Cancer Biol. 22:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin Q, Liu C, Yan C, Tao B, Li Z and Cai
Z: 5-aza-CdR induces the demethylation of Syk promoter in
nasopharyngeal carcinoma cell. Gene. 511:224–226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsin CH, Wu BC, Chuang CY, Yang SF, Hsieh
YH, Ho HY, Lin HP, Chen MK and Lin CW: Selaginella tamariscina
extract suppresses TPA-induced invasion and metastasis through
inhibition of MMP-9 in human nasopharyngeal carcinoma HONE-1 cells.
BMC Complement Altern Med. 13:2342013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Isobe K, Ito H, Shigematsu N, Kawada T,
Yasuda S, Hara R, Machida N, Takano H, Uchida Y, Uno T, et al:
Advanced nasopharyngeal carcinoma treated with chemotherapy and
radiotherapy: Distant metastasis and local recurrence. Int J Oncol.
12:1183–1187. 1998.PubMed/NCBI
|
|
10
|
He X, Ye M, Guo X, Pan Z, Zhang Z, He S
and Liu T: Treatment outcome of patients with stages I–II
nasopharyngeal carcinoma after late course accelerated
hyperfractionation radiotherapy alone. Oral Oncol. 48:1058–1063.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Wei J, Kanada M, Yan L, Zhang Z,
Watanabe H and Terakaw S: Inhibition of store-operated Ca2+ entry
suppresses EGF-induced migration and eliminates extravasation from
vasculature in nasopharyngeal carcinoma cell. Cancer Lett.
336:390–397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao
L, Huang J, Yu Y, Fan XG, Yan Z, et al: HMGB1 in health and
disease. Mol Aspects Med. 40:1–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ko YB, Kim BR, Nam SL, Yang JB, Park SY
and Rho SB: High-mobility group box 1 (HMGB1) protein regulates
tumor-associated cell migration through the interaction with BTB
domain. Cell Signal. 26:777–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kang R, Tang D, Schapiro NE, Loux T,
Livesey KM, Billiar TR, Wang H, Van Houten B, Lotze MT and Zeh HJ:
The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor
growth by regulating mitochondrial bioenergetics. Oncogene.
33:567–577. 2014. View Article : Google Scholar
|
|
16
|
Tang D, Kang R, Zeh HJ III and Lotze MT:
High-mobility group box 1 and cancer. Biochim Biophys Acta.
1799:131–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo J, Chen L, Luo N, Yang W, Qu X and
Cheng Z: Inhibition of TMEM45A suppresses proliferation, induces
cell cycle arrest and reduces cell invasion in human ovarian cancer
cells. Oncol Rep. 33:3124–3130. 2015.PubMed/NCBI
|
|
18
|
Hua YQ, Ouyang HQ, Chen Z, Meng ZQ, Luo
JM, Lin JH, Zhou ZH, Chen H, Wang K and Liu LM: Promoted cancer
growth by stimulating cell proliferation and decreasing apoptosis
using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1
cells. Biomed Pharmacother. 65:123–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu JG, Peng W, Yi J, Wu YB, Chen TQ, Wong
KH and Wu JZ: Chemical composition, antimicrobial activity against
Staphylococcus aureus and apro-apoptotic effect in SGC-7901 of the
essential oil from Toona sinensis (A. Juss) Roem leaves. J
Ethnopharmacol. 154:198–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arranz-Valsero I, Soriano-Romaní L,
García-Posadas L, López-García A and Diebold Y: IL-6 as a corneal
wound healing mediator in an in vitro scratch assay. Exp Eye Res.
125:183–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang XK, Yang YD, Tang SQ, et al:
Inhibitory Effect of Polysaccharides from Scutellaria barbata D.
Don on invasion and metastasis of 95-D cells lines via regulation
of C-MET and E-CAD expressions. Trop J Pharm Res. 12:517–522.
2013.
|
|
22
|
Lii CK, Lei YP, Yao HT, Hsieh YS, Tsai CW,
Liu KL and Chen HW: Chrysanthemum morifolium Ramat. Reduces the
oxidized LDL-induced expression of intercellular adhesion
molecule-1 and E-selectin in human umbilical vein endothelial
cells. J Ethnopharmacol. 128:213–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Chow VT and Jois SD: A novel, rapid
and sensitive heterotypic cell adhesion assay for CD2-CD58
interaction, and its application for testing inhibitory peptides. J
Immunol Methods. 291:39–49. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao Z and Shulan Z: Inhibition effect of
Guizhi-Fuling-decoction on the invasion of human cervical cancer. J
Ethnopharmacol. 120:25–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rubinson DA, Dillon CP, Kwiatkowski AV,
Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus
MT, et al: A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Völp K, Brezniceanu ML, Bösser S, Brabletz
T, Kirchner T, Göttel D, Joos S and Zörnig M: Increased expression
of high mobility box1 (HMGBl) is associated with an elevated level
of the anti-apoptotic c-IAP2 protein inhuman colon carcinomas. Gut.
55:234–242. 2006. View Article : Google Scholar
|
|
27
|
Zhou S, Zheng T, Chen Y, Zhang J, Li L, Lu
F and Zhu JJ: Toward therapeutic effects evaluation of chronic
myeloid leukemia drug: Electrochemical platform for caspase-3
activity sensing. Biosens Bioelectron. 61:648–654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee MS, Ha JH, Yoon HS, Lee CK and Chi SW:
Structural basis for the conserved binding mechanism of
MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Biochem Biophys Res Commun. 445:120–125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghosh S, Bishayee K, Paul A, Mukherjee A,
Sikdar S, Chakraborty D, Boujedaini N and Khuda-Bukhsh AR:
Homeopathic mother tincture of Phytolacca decandra induces
apoptosis in skin melanoma cells by activating caspase-mediated
signaling via reactive oxygen species elevation. J Integr Med.
11:116–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Antonsson B: Bax and other pro-apoptotic
Bcl-2 family 'killer-proteins' and their victim the mitochondrion.
Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Breznieeanu ML, Völp K, Bösser S, Solbach
C, Lichter P, Joos S and Zörnig M: HMGB1 inhibits cell death in
yeast and malnl Tlalian cells and is abundantly expressed in human
breast carcinoma. FASEB J. 17:1295–1297. 2003.
|
|
32
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taguchi A, Blood DC, del Toro G, Canet A,
Lee DC, Qu W, Tanji N, Lu Y, et al: Blockade of RAGE-amphoterin
signalling suppresses tumour growth and metastases. Nature.
405:354–360. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arumugam T, Simeone DM, Schmidt AM and
Logsdon CD: S100P stimulates cell proliferation and survival via
receptor for activated glycation end products (RAGE). J Biol Chem.
279:5059–5065. 2004. View Article : Google Scholar
|
|
35
|
Park JS, Arcaroli J, Yum HK, Yang H, Wang
H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ and Abraham
E: Activation of gene expression in human neutrophils by high
mobility group box 1 protein. Am J Physiol Cell Physiol.
284:C870–C879. 2003. View Article : Google Scholar : PubMed/NCBI
|
